Efficacy and safety of Aurantii Fructus Immaturus flavonoid Tablets vs. domperidone for functional dyspepsia: a multicenter, double-blind, double-dummy, randomized controlled phase III trial
Acta Gastro Enterologica Belgica · 2024
DOI: 10.51821/87.4.13488 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Acta Gastro Enterologica Belgica, 2024. Verfasst von M Wei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Jiangsu Provincial Hospital, Nanjing, China. Hauptthemen laut MEDLINE: Domperidone, Dyspepsia, Flavonoids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Background
The clinical management of functional dyspepsia (FD) is challenging. This study evaluated the efficacy and safety of Aurantii Fructus Immaturus flavonoid (AFIF) tablets vs. domperidone for FD.
Methods
This multicenter, randomized, double-blind, doubledummy, positive-controlled trial recruited FD patients, who were randomized 1:1 to the AFIF (AFIF and domperidone placebo) and domperidone (domperidone and AFIF placebo) groups. The primary endpoint was the rate of disappearance of all four FD symptoms (postprandial feeling of fullness, early satiety, upper abdominal pain, and upper abdominal burning sensation) after 4 treatment weeks.
Results
Totally 120 and 119 patients were included in the AFIF and domperidone groups, respectively. The rates of disappearance of all four symptoms after 4 treatment weeks were 28.33% and 31.93% in the AFIF and domperidone groups, respectively (p=0.5748). The rate of disappearance of all four symptoms 4 weeks after treatment discontinuation was significantly higher in the AFIF (21.05%) compared with the domperidone group (4.39%, p=0.0002). The gastric emptying rates 2h after a meal were significantly increased in both AFIF (7.58%, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Traditional Chinese Medicine, Jiangsu Provincial Hospital, Nanjing, China.
- GCP center of Jiangsu Province Hospital, Nanjing, China.
- Department of Gastroenterology, Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, China.
- Department of Nuclear Medicine, Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, China.
- Department of Liver, Spleen and Stomach Diseases, Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, China.
- Department of Hepatobiliary, Spleen and Stomach, Affiliated Hospital of Henan Academy of Traditional Chinese Medicine, Zhengzhou, China.
Zitieren
APA
Wei, M., Chai, Y., Shen, H., Du, M., Zhou, X., Liu, T., Yang, X., Li, S., Sun, J., & Ge, Y. (2024). Efficacy and safety of Aurantii Fructus Immaturus flavonoid Tablets vs. domperidone for functional dyspepsia: a multicenter, double-blind, double-dummy, randomized controlled phase III trial. Acta Gastro Enterologica Belgica. https://doi.org/10.51821/87.4.13488
Vancouver
Wei M, Chai Y, Shen H, Du M, Zhou X, Liu T, et al. Efficacy and safety of Aurantii Fructus Immaturus flavonoid Tablets vs. domperidone for functional dyspepsia: a multicenter, double-blind, double-dummy, randomized controlled phase III trial. Acta Gastro Enterologica Belgica. 2024. doi:10.51821/87.4.13488
BibTeX
@article{Wei2024,
author = {Wei, M and Chai, Y and Shen, H and Du, M and Zhou, X and Liu, T and Yang, X and Li, S and Sun, J and Ge, Y},
title = {Efficacy and safety of Aurantii Fructus Immaturus flavonoid Tablets vs. domperidone for functional dyspepsia: a multicenter, double-blind, double-dummy, randomized controlled phase III trial},
journal = {Acta Gastro Enterologica Belgica},
year = {2024},
doi = {10.51821/87.4.13488}
}
EUVIMED